市場調查報告書
商品編碼
1562247
歐洲近視治療市場預測至 2030 年 - 區域分析 - 按類型、治療、年齡層和最終用戶Europe Myopia Treatment Market Forecast to 2030 - Regional Analysis - by Type, Treatment, Age Group, and End User |
2022年歐洲近視治療市值為25.1879億美元,預計2030年將達到47.4613億美元;預計2022年至2030年複合年成長率為8.2%。
近視治療意識的提高推動了歐洲近視治療市場
人們對近視治療選擇的認知不斷提高,推動了近視治療市場的大幅成長。最近的一項市場分析顯示,人們對近視管理策略的認知不斷提高,尤其是家長和眼科保健專業人士,導致近視控制措施的實施大幅增加。全球眼保健領域的領導者正在與該國三所最好的驗光學校合作,從 2024 年開始為試點小組提供擴展近視治療。近視得不到控制的後果,人們已經顯著轉向主動的近視管理方法。這一趨勢進一步推動了角膜塑形術和藥物干預等近視治療技術的採用,導致市場規模顯著成長,在過去兩年成長了25%以上。提高人們對近視作為公共衛生問題的認知並促進近視管理解決方案的可行性的集體努力正在推動市場成長並培育積極主動的視力保健文化。這種勢頭可能會繼續推動近視治療的進步,強調意識在塑造近視管理和治療策略方面的關鍵作用。
歐洲近視治療市場概況
歐洲近視治療市場包括德國、法國、英國、西班牙、義大利和歐洲其他地區的綜合市場。歐洲在全球近視治療市場中佔據重要地位,預計在預測期內將出現強勁的成長。由於老年人口的增加、歐洲對預防保健的日益重視以及該地區推出的產品數量的增加,預計該地區的市場將成長。德國老年人口的廣泛增加為該國更多地採用眼保健補充劑提供了有利可圖的機會。 《2017年世界人口老化》顯示,2017年德國60歲以上人口約佔總人口的28%,預計到2050年將上升至近37.6%。男性為78 歲。如此高的預期壽命可能會影響眼睛健康,最終在預測期內推動德國近視治療市場的發展。
歐洲近視治療市場收入及 2030 年預測(百萬美元)
歐洲近視治療市場細分
歐洲近視治療市場按類型、治療、年齡層、最終用戶和國家分類。
根據類型,歐洲近視治療市場分為高度近視、退化性近視和進行性近視。到 2022 年,高度近視細分市場將佔據歐洲近視治療市場最大佔有率。
在治療方面,歐洲近視治療市場細分為低劑量阿托品眼藥水、隱形眼鏡、角膜塑形鏡和屈光手術。到2022年,低劑量阿托品眼藥水區隔市場將佔據歐洲近視治療市場最大佔有率。
依年齡層別分類,歐洲近視治療市場分為成人近視和兒童近視。到 2022 年,成人近視細分市場將佔據更大的歐洲近視治療市場。
根據最終用戶,歐洲近視治療市場分為醫院和診所、專科診所和屈光手術中心。 2022 年,醫院和診所細分市場佔據歐洲近視治療市場最大佔有率。
依國家分類,歐洲近視治療市場分為德國、英國、義大利、法國、西班牙和歐洲其他地區。 2022年,德國在歐洲近視治療市場佔有率中佔據主導地位。
Alcon AG、Bausch Health Companies Inc、Carl Zeiss AG、CooperVision Inc、Eyes Vision SL、Haag-Streit AG、Johnson & Johnson Vision Care Inc、Nidek Co Ltd 和 Ziemer Ophthalmic Systems AG 是歐洲近視領域的領先公司之一治療市場。
The Europe myopia treatment market was valued at US$ 2,518.79 million in 2022 and is expected to reach US$ 4,746.13 million by 2030; it is estimated to register a CAGR of 8.2% from 2022 to 2030.
Increased Awareness of Myopia Treatment drives Europe Myopia Treatment Market
The heightened awareness of myopia treatment options drives the substantial growth of the myopia treatment market. A recent market analysis revealed that the increasing awareness of myopia management strategies, particularly among parents and eyecare professionals, has led to a significant upsurge in implementing myopia control measures. The leader in global eye care is teaming up with three of the best optometry schools in the country to provide extended myopia therapy to a pilot group starting in 2024. As awareness campaigns, educational initiatives, and extensive research studies continue to shed light on the potential consequences of unmanaged myopia, there has been a notable shift toward proactive myopia management approaches. This trend has furthered the adoption of myopia treatment technologies, such as orthokeratology and pharmaceutical interventions, resulting in a remarkable increase in the market size, which has grown by over 25% in the last two years. The collective efforts to raise awareness about myopia as a public health concern and to promote the viability of myopia management solutions are propelling market growth and fostering a culture of proactive vision care. This momentum is likely to continue driving advancements in myopia treatment, emphasizing the pivotal role of awareness in shaping the landscape of myopia management and treatment strategies.
Europe Myopia Treatment Market Overview
The Europe myopia treatment market includes the consolidated markets for Germany, France, the UK, Spain, Italy, and the Rest of Europe. Europe occupies a significant position in the global myopia treatment market and is estimated to register a robust growth rate during the forecast period. The market growth in the region is expected due to the increasing geriatric population, rising emphasis on preventive care in Europe, and rising number of product introductions in the region. Germany's extensively increasing geriatric population represents a lucrative opportunity for increased adoption of eye health supplements in the country. As per the "World Population Ageing 2017," in 2017, ~28% of the total population of Germany was aged 60 or more, and it is estimated to rise to nearly 37.6% by the year 2050. It also mentioned that life expectancy is projected to be 83 years for women and 78 years for men. Such higher life expectancy will likely impact eye health, eventually driving the Germany myopia treatment market during the forecast period.
Europe Myopia Treatment Market Revenue and Forecast to 2030 (US$ Million)
Europe Myopia Treatment Market Segmentation
The Europe myopia treatment market is categorized into type, treatment, age group, end user, and country.
Based on type, the Europe myopia treatment market is segmented into high myopia, degenerative myopia, and progressive myopia. The high myopia segment held the largest Europe myopia treatment market share in 2022.
In terms of treatment, the Europe myopia treatment market is segmented into low-dose atropine eye drops, contact lenses, ortho-k, and refractive surgery. The low-dose atropine eye drops segment held the largest Europe myopia treatment market share in 2022. Furthermore, the refractive surgery segment is subcategorized into LASIK and PRK.
By age group, the Europe myopia treatment market is bifurcated into adult myopia and childhood myopia. The adult myopia segment held a larger Europe myopia treatment market share in 2022.
Based on end user, the Europe myopia treatment market is categorized into hospitals and clinics, specialty clinics, and refractive surgery centers. The hospitals and clinics segment held the largest Europe myopia treatment market share in 2022.
Based on country, the Europe myopia treatment market is categorized into Germany, the UK, Italy, France, Spain, and the Rest of Europe. Germany dominated the Europe myopia treatment market share in 2022.
Alcon AG, Bausch Health Companies Inc, Carl Zeiss AG, CooperVision Inc, Eyes Vision SL, Haag-Streit AG, Johnson & Johnson Vision Care Inc, Nidek Co Ltd, and Ziemer Ophthalmic Systems AG are among the leading companies operating in the Europe myopia treatment market.